Neurim Pharmaceuticals initiates Phase III study of Paediatric Prolonged-Release Melatonin in children with Autistic Spectrum Disorders, suffering from sleep disturbances

  • Text size: A A A
  • Circadin
  • Recent news

    • Slenyto (PedPRM) is now available in Switzerland!
    • Slenyto (PedPRM) is now available in Norway!
    • Neurim Pharmaceuticals attends the ESCAP Congress in Vienna, Austria, 30 June – 2 July 2019
  • Partners